La Jolla Pharmaceutical Company (LJPC)

NASDAQ: LJPC · IEX Real-Time Price · USD
3.16
-0.03 (-0.94%)
Jul 1, 2022 12:51 PM EDT - Market open

Stock Price Forecast

According to 6 stock analysts, the average 12-month stock price forecast for LJPC stock is $4.08, which predicts an increase of 29.11%. The lowest target is $4.04 and the highest is $4.2. On average, analysts rate LJPC stock as a sell.
Analyst Consensus: Sell
Target Low Average Median High
Price $4.04 $4.08 $4.08 $4.2
Change +27.85% +29.11% +29.11% +32.91%

Analyst Ratings

The average analyst rating for LJPC stock from 6 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 000000
Buy 000000
Hold 333333
Sell 111111
Strong Sell 222222
Total 666666

Financial Forecast

Revenue This Year
53.84M
Decreased by -28.90%
Revenue Next Year
65.23M
Increased by 21.15%
EPS This Year
0.04
Decreased by -94.33%
EPS Next Year
0.23
Increased by 475.00%
Year 2017201820192020202120222023202420252026
Revenue
-10.06M23.05M33.42M75.72M53.84M65.23M77.41M91.01M109.14M
Revenue Growth
--
129.26%
44.96%
126.58%
-28.90%
21.15%
18.69%
17.57%
19.92%
EPS
-5.41-7.85-4.30-1.440.720.040.230.481.172.94
EPS Growth
-----
-94.33%
475.00%
104.35%
145.10%
150.00%
No. Analysts -----33311

Revenue Forecast

Revenue 20222023202420252026
High 55.4M 67.1M 79.7M 95.6M 113.5M
Avg 53.8M 65.2M 77.4M 91.0M 109.1M
Low 51.7M 62.7M 74.4M 88.3M 105.9M

Revenue Growth

Revenue Growth 20222023202420252026
High
-29.9%
24.7%
22.2%
23.4%
24.7%
Avg
-31.9%
21.2%
18.7%
17.6%
19.9%
Low
-34.6%
16.4%
14.0%
14.0%
16.3%

EPS Forecast

EPS 20222023202420252026
High 0.04 0.24 0.49 1.23 3.05
Avg 0.04 0.23 0.48 1.17 2.94
Low 0.04 0.23 0.46 1.14 2.85

EPS Growth

EPS Growth 20222023202420252026
High
-92.2%
491.9%
110.4%
157.4%
160.0%
Avg
-92.5%
475.0%
104.3%
145.1%
150.0%
Low
-92.7%
452.5%
96.3%
137.7%
142.5%